In recent years, studies have reported that LXA4 exerts a notable anti-inflammatory and neuroprotective effect by activating its receptor formyl peptide receptor 2 (FPR2) in animal models of ischemic stroke, subarachnoid hemorrhage and ICH [17-19]. This evidence concerns the gene FPR2 and ischemic stroke.